NCT04131062View on ClinicalTrials.gov

Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants

NACompletedINTERVENTIONAL
Enrollment

703

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

May 19, 2022

Study Completion Date

May 19, 2022

Conditions
Lynch Syndrome
Interventions
BEHAVIORAL

Electronic Consent (iPad)

Participants who receive the intervention will be consented using an electronic app presented via iPad and developed according to the Sage eConsent framework.

Trial Locations (1)

17821

Geisinger, Danville

Sponsors

Lead Sponsor

Geisinger Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Geisinger Clinic

OTHER